Performance analysis of Rocket Pharmaceuticals (RCKT)
Annual Return
Over the past 3 years, RCKT has had an average annual return of -49.11%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, RCKT has had an average annual return of -41.63%, underperforming the benchmark SPY, which returned +14.05% annual.
Over the past 10 years, RCKT has had an average annual return of -22.28%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Feb 18, 2015, RCKT has had an average annual return of -17.09%, underperforming the benchmark SPY, which returned +13.95% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -17.70% | -72.07% | -58.06% | +53.15% | -10.36% | -60.19% | +140.96% | +53.57% | +41.95% | -57.21% | -46.16% | +88.83% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.89% | +44% | -28.54% | -2.82% | -11.79% | -5.86% | -17.70% | ||||||
| 2025 | -14.57% | -12.00% | -29.43% | +14.39% | -67.10% | -2.39% | +24.49% | +7.55% | -0.66% | +15.68% | -9.29% | +2.67% | -72.07% |
| 2024 | -4.14% | +1.98% | -8.05% | -20.12% | -0.94% | +0.99% | +12.40% | -22.11% | -2.01% | -9.85% | -13.58% | -12.64% | -58.06% |
| 2023 | +11.04% | -11.60% | -10.82% | +4.61% | +16.79% | -5.07% | -9.16% | -13.30% | +30.92% | -11.66% | +28.89% | +28.46% | +53.15% |
| 2022 | -23.78% | +7.04% | -10.96% | -35.18% | +15.29% | +16.10% | +5.39% | +6.27% | +3.57% | +16.92% | +1.18% | +3.65% | -10.36% |
| 2021 | +0.44% | +0.91% | -20.17% | +3.31% | -7.29% | +4.21% | -19.12% | -4.50% | -12.63% | -0.60% | -17.77% | -10.64% | -60.19% |
| 2020 | -10.02% | -4.83% | -28.43% | +6.11% | +27.08% | +11.28% | +12.42% | +8.67% | -10.60% | +22.23% | +10.81% | +77.13% | +140.96% |
| 2019 | -2.96% | +21.06% | +0.74% | +5.82% | -12.01% | -8.14% | -18.80% | -10.92% | +7.37% | +24.80% | +20.98% | +29.39% | +53.57% |
| 2018 | +82.37% | -10.82% | +10.43% | -8.06% | +12.77% | +0.98% | +4.49% | +16.29% | +3.22% | -35.66% | +1.71% | -8.01% | +41.95% |
| 2017 | -73.77% | -0% | +24.97% | -0% | -15.00% | +11.79% | -51.97% | +11.77% | +74.53% | +41.56% | -8.33% | +12.99% | -57.21% |
Drawdown analysis of Rocket Pharmaceuticals (RCKT)
The maximum drawdown for the RCKT was -96.70%, occurring on May 27, 2025. This drawdown has not yet recovered.
The current RCKT drawdown is -95.91%.
Since Feb 18, 2015 RCKT has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 3 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.70% | Jul 24, 2015 | 2474 | May 27, 2025 | Ongoing | Ongoing | Ongoing |
| -22.13% | Feb 23, 2015 | 42 | Apr 23, 2015 | 4 | Apr 29, 2015 | 46 |
| -21.27% | Apr 29, 2015 | 45 | Jul 2, 2015 | 14 | Jul 23, 2015 | 59 |